Top Story

Management of localized prostate cancer has improved in community-based practices

Management of localized prostate cancer has improved in community-based practices
July 7, 2015

The use of active surveillance and watchful waiting for patients with low-risk prostate cancer significantly increased since 2010 in community-based practices, according to study findings.

Further, high-risk disease was treated more frequently with curative local treatment rather than androgen deprivation therapy alone, results also showed.

Emmanuel S. Antonarakis, MBBCh In the JournalsPerspective

Men with AR-V7 variant may benefit from taxanes for advanced prostate cancer

July 6, 2015
Men with advanced prostate cancer who have the androgen receptor splice variant-7 respond to chemotherapy equally as well as those who do not have the variant, according…
Scott E. Eggener, MD In the Journals

Prostate cancer screening has declined in older men following guideline revisions

June 26, 2015
Prostate cancer screening rates significantly decreased among men aged 50 years or older since the release of a U.S. Preventive Services Task Force guideline that…
Derek Raghavan EditorialPublication Exclusive

Provocative data reveal changing paradigms in prostate cancer

HemOnc Today, June 25, 2015
Derek Raghavan, MD, PhD
The pace of research in prostate cancer is increasing, and several interesting themes have emerged recently.There are provocative data that suggest that the use of…
CME
Hematology Oncology Case Consults

The Patient with Melanoma

No commercial support for this activity.

This CME activity will focus on the diagnosis and management of patients with melanoma.
More »
Video
thumbnail for video 4040822599001

Routine PSA screening for most men not ready for ‘prime time’

February 10, 2015
Derek Raghavan, MD, PhD, FACP, FRACP, FASCO, president of Levine Cancer Institute at Carolinas HealthCare System and…
More »
CME
Hematology Oncology Case Consults

Diagnosis and Management of Hemophilia

No commercial support for this activity.

This CME activity will focus on the diagnosis and management of the patient with hemophilia supplemented with a case…
More »
Matthew R. Cooperberg, MD, MPH In the Journals

Management of localized prostate cancer has improved in community-based practices

July 7, 2015
The use of active surveillance and watchful waiting for patients with low-risk prostate cancer significantly increased since 2010 in community-based…
Emmanuel S. Antonarakis, MBBCh In the JournalsPerspective

Men with AR-V7 variant may benefit from taxanes for advanced prostate cancer

July 6, 2015
Men with advanced prostate cancer who have the androgen receptor splice variant-7 respond to chemotherapy equally as well as those who do not have…
Scott E. Eggener, MD In the Journals

Prostate cancer screening has declined in older men following guideline revisions

June 26, 2015
Prostate cancer screening rates significantly decreased among men aged 50 years or older since the release of a U.S. Preventive Services Task Force…
Derek Raghavan EditorialPublication Exclusive

Provocative data reveal changing paradigms in prostate cancer

HemOnc Today, June 25, 2015
Derek Raghavan, MD, PhD
The pace of research in prostate cancer is increasing, and several interesting themes have emerged recently.There are provocative data that suggest…
Jorge Garcia Meeting News Coverage

Top Takeaways from ASCO: Prostate Cancer

June 24, 2015
CHICAGO – The efficacy of systemic docetaxel for the treatment of prostate cancer is “perhaps the most exciting data for prostate…
Association News

Urological society presents Distinguished Service Award

June 20, 2015
The Chicago Urological Society presented its Distinguished Service Award to Robert Flanigan, MD, chair of the department of urology at Loyola…
In the Journals

Radiotherapy has modest impact on quality of life when added to ADT

June 18, 2015
The addition of radiotherapy to androgen deprivation therapy significantly improved OS with only minor and temporary negative effects on…
In the Journals

ADT may impair cognitive function in patients with prostate cancer

June 16, 2015
Men with prostate cancer who are treated with androgen deprivation therapy are more likely to have cognitive impairments after 6 months of treatment…
Meeting News CoveragePerspective

Radiotherapy plus hormone therapy improves PFS after radical prostatectomy

June 2, 2015
CHICAGO — The addition of short hormone therapy to radiation therapy improved 5-year PFS in a cohort of patients with prostate cancer who had a…
Meeting News Coverage

Intermittent ADT fails to reduce toxicity in metastatic prostate cancer

June 1, 2015
CHICAGO — Intermittent androgen deprivation therapy increased ischemic and thrombotic events in a cohort of older men with metastatic prostate…
More Headlines »
morganatic-roan